Oral presentation at IAE World Congress of Epidemiology in Japan.

27th October 2017

Petra Seibold ( Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany) gave an oral presentation at the 21st International Epidemiological Association (IEA) World Congress of Epidemiology (WCE2017) about: Quality of Life and patient-reported early adverse effects in prostate cancer patients treated with radiotherapy in the multi-centre observational REQUITE study.

The 21st World Congress of Epidemiology took place at Sonic City in Saitama, Japan on August 19-22, 2017. The main theme was “Global / Regional / Local Health and Epidemiology in a Changing World” an opportunity to exchange information about the development of epidemiology in all the fields and to strengthen the relationship among epidemiologists in the world.

REQUITE: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 601826